RHHBY Stock Recent News
RHHBY LATEST HEADLINES
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer's development portfolio is being presented at the Alzheimer's Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer's across the entire patient journey. Featured oral presentations include the latest results from the ongoing.
Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday.
Roche Holding AG (OTCQX:RHHBY) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Alan Hippe - Chief Financial Officer Bruno Eschli - Head of Investor Relations Matthew Sause - Chief Executive Officer Teresa A. Graham - Chief Executive Officer of Roche Pharmaceuticals Thomas Schinecker - Group Chief Executive Officer Conference Call Participants Emmanuel Douglas Papadakis - Deutsche Bank AG, Research Division James Patrick Quigley - Goldman Sachs Group, Inc., Research Division Justin Steven Barrie Smith - Sanford C.
RHHBY posts solid first-half 2025 growth on strong drug demand, but pipeline setbacks and biosimilar hits remain headwinds.
Roche Holding AG's Q2 and 1H 2025 earnings will, initially, broadly please the market despite recent pipeline and commercial setbacks. The pharmaceuticals division delivered strong revenue growth, up 10% year-over-year to $24bn in 1H25. The diagnostics division revenues remained flat at $7bn, attributed to specific market factors in China by Roche.
Lead With Us -- a promise for innovative partnerships, better insights, faster support, and improved healthcare outcomes. INDIANAPOLIS and CHICAGO , July 24, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase its science-driven leadership in diagnostics at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) Scientific Meeting and Clinical Lab Expo, held July 28–31 in Chicago.
Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S. government, which is pressuring drugmakers to cut prices, Roche's CEO said on Thursday.
Swiss drugmaker Roche reported first-half operating profit up 6% on Thursday at a forecast-beating 12 billion Swiss francs ($15.15 billion) and also confirmed its full-year outlook.
Basel, 24 July 2025 Group sales grew by 7%1 at constant exchange rates (CER; 4% in CHF), driven by strong demand for medicines. Pharmaceuticals Division sales rose by 10% (6% in CHF), with Phesgo (breast cancer), Xolair (food allergies), Hemlibra (haemophilia A), Vabysmo (severe eye diseases) and Ocrevus (multiple sclerosis) being the top growth drivers.
East Longmeadow, MA, July 23, 2025 (GLOBE NEWSWIRE) -- The Roche Associates, Inc. was recently named “Top Senior Living Marketing Agency for 2025” by Elder Care Review. The Roche Associates, Inc. emerged as the Top Senior Living Marketing Agency for 2025” after an extensive evaluation by an expert panel of C-level executives, industry thought leaders, and Elder Care Review's editorial board. Elder Care Review is a monthly magazine, focused on the senior housing and senior care industries. Elder Care Review magazine has 113,000 qualified print and digital subscribers (41k print and 72k digital).